共 50 条
- [41] Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialLANCET, 2023, 402 (10417): : 2077 - 2090Rovin, Brad H.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USABarratt, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAAlpers, Charles E.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USABieler, Stewart论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAChae, Dong-Wan论文数: 0 引用数: 0 h-index: 0机构: Seoul Red Cross Hosp, Dept Internal Med, Seoul, South Korea Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USADiva, Ulysses A.论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAFloege, Juergen论文数: 0 引用数: 0 h-index: 0机构: RWTH Aachen Univ Hosp, Div Nephrol, Aachen, Germany Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAGesualdo, Loreto论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Nephrol Dialysis & Transplantat Unit, Bari, Italy Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAInrig, Jula K.论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAKohan, Donald E.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Sch Med, Div Nephrol, Salt Lake City, UT USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAKomers, Radko论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAKooienga, Laura Ann论文数: 0 引用数: 0 h-index: 0机构: Colorado Kidney Care, Denver, CO USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USALafayette, Richard论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Med Ctr, Div Nephrol, Stanford, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAMaes, Bart论文数: 0 引用数: 0 h-index: 0机构: AZ Delta, Dept Nephrol, Roeselare, Belgium Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAMalecki, Robert论文数: 0 引用数: 0 h-index: 0机构: Miedzyleski Specialist Hosp, Dept Nephrol, Warsaw, Poland Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAMercer, Alex论文数: 0 引用数: 0 h-index: 0机构: JAMCO Pharm Consulting, Stockholm, Sweden Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USANoronha, Irene L.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Div Nephrol, Sao Paulo, Brazil Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAOh, Se Won论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Coll Med, Anam Hosp, Dept Internal Med, Seoul, South Korea Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAPeh, Chen Au论文数: 0 引用数: 0 h-index: 0机构: Royal Adelaide Hosp, Adelaide, SA, Australia Univ Adelaide, Adelaide, SA, Australia Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAPraga, Manuel论文数: 0 引用数: 0 h-index: 0机构: Res Inst Hosp 12 Octubre I 12, Madrid, Spain Univ Complutense Madrid, Dept Med, Madrid, Spain Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAPreciado, Priscila论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USARadhakrishnan, Jai论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Irving Med Ctr, Div Nephrol, New York, NY USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USARheault, Michelle N.论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Sch Med, Div Pediat Nephrol, Minneapolis, MN USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USARote, William E.论文数: 0 引用数: 0 h-index: 0机构: Travere Therapeut, San Diego, CA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USATang, Sydney C. W.论文数: 0 引用数: 0 h-index: 0机构: Univ Hong Kong, Dept Med, Div Nephrol, Sch Clin Med, Hong Kong, Peoples R China Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USATesar, Vladimir论文数: 0 引用数: 0 h-index: 0机构: Charles Univ Prague, Dept Nephrol, Gen Univ Hosp, Prague, Czech Republic Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USATrachtman, Howard论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Dept Pediat, Div Nephrol, Ann Arbor, MI USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USATrimarchi, Hernan论文数: 0 引用数: 0 h-index: 0机构: British Hosp Buenos Aires, Nephrol Serv, Buenos Aires, DF, Argentina Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USATumlin, James A.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Div Renal, Atlanta, GA USA NephroNet Clin Trials Consortium, Atlanta, GA USA Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAWong, Muh Geot论文数: 0 引用数: 0 h-index: 0机构: Concord Repatriat Gen Hosp, Dept Renal Med, Concord, NSW, Australia Univ Sydney, Concord Clin Sch, Concord, NSW, Australia Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USAPerkovic, Vlado论文数: 0 引用数: 0 h-index: 0机构: Univ New South Wales, Fac Med & Hlth, Sydney, NSW, Australia Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH USA
- [42] A Randomized Alendronate-Controlled Trial of Romosozumab: Results of the Phase 3 ARCH Study (Active-contRolled fraCture study in postmenopausal women with osteoporosis at High risk).JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S54 - S55Saag, Kenneth G.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama, Tuscaloosa, AL 35487 USA Univ Alabama, Tuscaloosa, AL 35487 USAPetersen, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Univ Alabama, Tuscaloosa, AL 35487 USABrandi, Maria Luisa论文数: 0 引用数: 0 h-index: 0机构: Univ Florence, Florence, Italy Univ Alabama, Tuscaloosa, AL 35487 USAKaraplis, Andrew论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Montreal, PQ, Canada Univ Alabama, Tuscaloosa, AL 35487 USA论文数: 引用数: h-index:机构:Thomas, Thierry论文数: 0 引用数: 0 h-index: 0机构: CHU St Etienne, St Etienne, France Univ Alabama, Tuscaloosa, AL 35487 USAMaddox, Judy论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Univ Alabama, Tuscaloosa, AL 35487 USAFan, Michelle论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Univ Alabama, Tuscaloosa, AL 35487 USAMeisner, Paul论文数: 0 引用数: 0 h-index: 0机构: UCB Pharma, Brussels, Belgium Univ Alabama, Tuscaloosa, AL 35487 USAGrauer, Andreas论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Univ Alabama, Tuscaloosa, AL 35487 USA
- [43] Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge studyLANCET INFECTIOUS DISEASES, 2020, 20 (04): : 435 - 444Liebowitz, David论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USAGottlieb, Keith论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USAKolhatkar, Nikita S.论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USAGarg, Shaily J.论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USAAsher, Jason M.论文数: 0 引用数: 0 h-index: 0机构: Biomed Adv Res & Dev Author, Washington, DC USA Vaxart, San Francisco, CA 94080 USANazareno, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USAKim, Kenneth论文数: 0 引用数: 0 h-index: 0机构: Ark Clin Res, Long Beach, CA USA Vaxart, San Francisco, CA 94080 USAMcIlwain, David R.论文数: 0 引用数: 0 h-index: 0机构: WCCT Global, Costa Mesa, CA USA Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA Vaxart, San Francisco, CA 94080 USATucker, Sean N.论文数: 0 引用数: 0 h-index: 0机构: Vaxart, San Francisco, CA 94080 USA Vaxart, San Francisco, CA 94080 USA
- [44] Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trialsHUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (01) : 24 - 32Citrome, Leslie论文数: 0 引用数: 0 h-index: 0机构: New York Med Coll, Valhalla, NY 10595 USA New York Med Coll, Valhalla, NY 10595 USAMeng, Xiangyi论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA New York Med Coll, Valhalla, NY 10595 USAHochfeld, Marla论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA New York Med Coll, Valhalla, NY 10595 USAStahl, Stephen M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, La Jolla, CA 92093 USA Univ Cambridge, Cambridge, England New York Med Coll, Valhalla, NY 10595 USA
- [45] Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 TrialCIRCULATION, 2011, 124 (18) : 1945 - U124Calhoun, David A.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USAWhite, William B.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Sch Med, Div Hypertens & Clin Pharmacol, Pat & Jim Calhoun Cardiol Ctr, Farmington, CT USA Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USAKrum, Henry论文数: 0 引用数: 0 h-index: 0机构: Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USAGuo, Weinong论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USABermann, Georgina论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Basel, Switzerland Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USATrapani, Angelo论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USALefkowitz, Martin P.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USAMenard, Joel论文数: 0 引用数: 0 h-index: 0机构: INSERM, CIC 9201, Paris, France Univ Paris 05, Paris, France Univ Alabama, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
- [46] Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study (vol 11, pg 787, 2010)EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (16) : 2773 - 2773Buynak论文数: 0 引用数: 0 h-index: 0
- [47] Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled studyJAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (03) : 315 - 325Hieda, Osamu论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan论文数: 引用数: h-index:机构:Fujikado, Takashi论文数: 0 引用数: 0 h-index: 0机构: Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanIshiko, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanHasebe, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Dept Ophthalmol 2, Kurashiki, Okayama, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan论文数: 引用数: h-index:机构:Takahashi, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanNakamura, Yo论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanSotozono, Chie论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanOshika, Tetsuro论文数: 0 引用数: 0 h-index: 0机构: Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanMorimoto, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Osaka Univ, Dept Adv Visual Neurosci, Grad Sch Med, Suita, Osaka, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanNishida, Kohji论文数: 0 引用数: 0 h-index: 0机构: Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanNishikawa, Noriko论文数: 0 引用数: 0 h-index: 0机构: Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanSong, Young-Seok论文数: 0 引用数: 0 h-index: 0机构: Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanTokutake, Tomoki论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Dept Ophthalmol, Gen Med Ctr, Okayama, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan论文数: 引用数: h-index:机构:Shigeno, Yuta论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanKurihara, Toshihide论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanNegishi, Kazuno论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanTsubota, Kazuo论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan Tsubota Lab Inc, Shinjuku Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanOno, Masafumi论文数: 0 引用数: 0 h-index: 0机构: Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanNakai, Tomoko论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Clin Biostat Course, Kyoto, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanTan, Donald论文数: 0 引用数: 0 h-index: 0机构: Singapore Natl Eye Ctr, Singapore, Singapore Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanTanaka, Shiro论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Clin Biostat Course, Kyoto, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, JapanKinoshita, Shigeru论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan
- [48] Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled studyJapanese Journal of Ophthalmology, 2021, 65 : 315 - 325Osamu Hieda论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTakahiro Hiraoka论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTakashi Fujikado论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologySatoshi Ishiko论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologySatoshi Hasebe论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyHidemasa Torii论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyHiroshi Takahashi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyYo Nakamura论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyChie Sotozono论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTetsuro Oshika论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTakeshi Morimoto论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyKohji Nishida论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyNoriko Nishikawa论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyYoung-Seok Song论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTomoki Tokutake论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyYasuyo Nishi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyYuta Shigeno论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyToshihide Kurihara论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyKazuno Negishi论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyKazuo Tsubota论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyMasafumi Ono论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyTomoko Nakai论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyDonald Tan论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyShiro Tanaka论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of OphthalmologyShigeru Kinoshita论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural University of Medicine,Department of Ophthalmology
- [49] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled StudySWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9SKavanaugh, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, San Diego, CA 92103 USA Univ Calif San Diego, San Diego, CA 92103 USAPuig, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Autonoma Barcelona, Barcelona, Spain Univ Calif San Diego, San Diego, CA 92103 USAGottlieb, A. B.论文数: 0 引用数: 0 h-index: 0机构: Tufts Med Ctr, Boston, MA USA Univ Calif San Diego, San Diego, CA 92103 USARitchlin, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, Rochester, NY USA Univ Calif San Diego, San Diego, CA 92103 USALi, S.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, San Diego, CA 92103 USAWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, San Diego, CA 92103 USAMendelsohn, A. M.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, San Diego, CA 92103 USASong, M.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, San Diego, CA 92103 USARahman, P.论文数: 0 引用数: 0 h-index: 0机构: Mem Univ, St John, NF, Canada Univ Calif San Diego, San Diego, CA 92103 USA论文数: 引用数: h-index:机构:
- [50] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDYANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738Kavanaugh, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, La Jolla, CA 92093 USA Univ Calif San Diego, La Jolla, CA 92093 USAPuig, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Autonoma Barcelona, E-08193 Barcelona, Spain Univ Calif San Diego, La Jolla, CA 92093 USAGottlieb, A.论文数: 0 引用数: 0 h-index: 0机构: Tufts Med Ctr, Boston, MA USA Univ Calif San Diego, La Jolla, CA 92093 USARitchlin, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, Rochester, NY 14627 USA Univ Calif San Diego, La Jolla, CA 92093 USALi, S.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, La Jolla, CA 92093 USAWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, La Jolla, CA 92093 USAMendelsohn, A. M.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, La Jolla, CA 92093 USASong, M.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Calif San Diego, La Jolla, CA 92093 USARahman, P.论文数: 0 引用数: 0 h-index: 0机构: Mem Univ Newfoundland, St John, NF, Canada Univ Calif San Diego, La Jolla, CA 92093 USA论文数: 引用数: h-index:机构: